When comparing ME/CFS patients to the healthy control participants (Figure 4A), there were no statistically significant differences detected in serum Lipopolysaccharide-binding protein (LBP) levels. The gene discussed is LBP; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.